Skip to main content
Top

Current Cardiology Reports

Issue 9/2022

Content (16 Articles)

Titin-related Cardiomyopathy: Is it a Distinct Disease?

  • Cardiomyopathy
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Celine F. Santiago, Inken G. Huttner, Diane Fatkin

Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy

Joyce N. Njoroge, Jennifer C. Mangena, Chiaka Aribeana, Victoria N. Parikh

Cardiovascular Damage in COVID-19: What We Know Two Years Later

  • Open Access
  • Myocarditis
  • Myocardial Disease (A Abbate and M Merlo, Section Editors)

Vincenzo Nuzzi, Eva Del Mestre, Alessia Degrassi, Daniel I. Bromage, Paolo Manca, Susan Piper, Jessica Artico, Piero Gentile, Paul A. Scott, Mario Chiatto, Marco Merlo, Nilesh Pareek, Mauro Giacca, Gianfranco Sinagra, Theresa A. McDonagh, Antonio Cannata

Keto is Trending: Implications for Body Weight and Lipid Management

  • Insulins
  • Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)

Carol F. Kirkpatrick, Kaye-Eileen Willard, Kevin C. Maki

SAMSON and the Nocebo Effect: Management of Statin Intolerance

  • Atorvastatin
  • Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)

Amrita Krishnamurthy, Corey Bradley, Rebecca Ascunce, Samuel M. Kim

Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity

Lucía Cobarro Gálvez, Emilio Arbas Redondo, Cristina Contreras Lorenzo, Teresa López Fernández

Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement

  • Cardio-Oncology (LA Baldassarre, Section Editor)

Javaria Ahmad, Anjani Muthyala, Ashish Kumar, Sourbha S. Dani, Sarju Ganatra

Health Disparities Across the Continuum of ASCVD Risk

Ankita Devareddy, Ashish Sarraju, Fatima Rodriguez

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence

  • Global Cardiovascular Health (L Sperling and D Gaita, Section Editors)

Kyriakos Dimitriadis, Emilia Lazarou, Panagiotis Tsioufis, Stergios Soulaidopoulos, Konstantinos Tsioufis

HIV and Global Cardiovascular Health

Anjali Wagle, Erin Goerlich, Wendy S. Post, Bethel Woldu, Katherine C. Wu, Allison G. Hays

Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes

  • Insulins
  • Diabetes and Cardiovascular Disease (D Bruemmer, Section Editor)

Keren Zhou, Diana Isaacs

Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations

Ozan Dikilitas, Daniel J. Schaid, Catherine Tcheandjieu, Shoa L. Clarke, Themistocles L. Assimes, Iftikhar J. Kullo

Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022

Mariem A. Sawan, Avery E. Calhoun, Kendra J. Grubb, Chandan M. Devireddy

Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas

Georgia Pitsava, Fabio R. Faucz, Constantine A. Stratakis, Fady Hannah-Shmouni

Racial Disparities in Cardiovascular Risk and Cardiovascular Care in Women

  • Care
  • Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)

Rachel-Maria Brown, Samia Tamazi, Catherine R. Weinberg, Aeshita Dwivedi, Jennifer H. Mieres

Tricuspid Valve Percutaneous Therapies

Bhaskar Bhardwaj, Joaquin E. Cigarroa, Firas Zahr

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME